There was a 54% reduction in hospitalization/death for outpatient use, proving the effectiveness of using convalescent plasma for treating mild-moderate COVID-19 in people with risk factors.[8] Limited supply, as many blood banks do not currently solicit donors. COVID-19 infected AN...